Journal of Psychoactive Drugs explained

Journal of Psychoactive Drugs
Cover:-->
Former Name:Journal of Psychedelic Drugs
Former Names:-->
Abbreviation:J. Psychoact. Drugs
Discipline:Pharmacology
Language:English
Editors:-->
Publisher:Taylor & Francis
History:1967–present
Impact:2.80
Impact-Year:2022
Issn:0279-1072
Eissn:2159-9777
Website:http://www.tandfonline.com/loi/ujpd20/
Link5:-->
Link5-Name:-->

The Journal of Psychoactive Drugs is a peer-reviewed medical journal on psychoactive drugs. It was established in 1967 by David E. Smith and is currently published five times per year by Taylor & Francis. It was previously titled Journal of Psychedelic Drugs until 1980.[1] [2] It was the first journal established in the United States to focus on psychoactive drug use, and continues to introduce groundbreaking work in topics such as drug use and criminality, therapeutic communities, dual diagnosis, psychotherapy/counseling, methadone maintenance treatment, and culturally-relevant substance abuse treatment. According to the Journal Citation Reports, the journal has a 2016 impact factor of 1.740.[3]

References

  1. Web site: Erowid Periodical Library: The Journal of Psychedelic Drugs . Erowid.org . 2008-10-07.
  2. Web site: Journal of Psychoactive Drugs information. 2022-02-24. www.tandfonline.com.
  3. Book: 2013 . Journal of Psychoactive Drugs . 2012 Journal Citation Reports . . Science . . Journal Citation Reports .